Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 11, 2002, Pages 1895-1902

  Lamb, E J ^a   Wong, T ^a   Smith, D J ^a   Simpson, D E ^a   Coakley, A J ^a   Moniz, C ^b   Muller, A F ^a  

^a KENT AND CANTERBURY HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALCOHOL; BIOCHEMICAL MARKER; CARBAMAZEPINE; CORTICOSTEROID; CREATININE; HORMONE; ORAL CONTRACEPTIVE AGENT; OSTEOCALCIN; PARATHYROID HORMONE; PYRIDINOLINE; STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTERITIS; FEMALE; FEMUR NECK; HUMAN; IRRITABLE COLON; MALE; METABOLIC BONE DISEASE; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; SPINE; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BONE DENSITY; BONE DISEASES, METABOLIC; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COLONIC DISEASES, FUNCTIONAL; CROHN DISEASE; FEMALE; FEMUR NECK; HUMANS; INFLAMMATORY BOWEL DISEASES; LUMBAR VERTEBRAE; MALE; MIDDLE AGED;

EID: 0036828702     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01363.x     Document Type: Article

References (42)

1. Compston JE, Judd D, Crawley EO, et al. Osteoporosis in patients with inflammatory bowel disease. Gut 1987: 28: 410-5.
2. Vogelsang H, Fereneci P, Woloszczuk FW, Resch H. Frotz HS, Gangl A. Bone disease in vitamin D-deficient patients with Crohn's disease. Dig Dis Sci 1989: 34: 1094-9.
3. Pigot F, Roux C, Chaussade S, et al. Low bone mineral density in patients with inflammatory bowel disease. Dig Dis Sci 1992: 37: 1396-403.
4. Roux C, Abitbol V, Chaussade S, et al. Bone loss in patients with inflammatory bowel disease: A prospective study. Osteoporosis Int 1995: 5: 156-60.
5. Abitbol V, Roux C, Chaussade S, et al. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 1995: 108: 417-22.
6. Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L. Shanahan F. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res 1995: 10: 250-6.
7. Bernstein CN, Seeger LL, Anton PA, et al. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: A pilot study. Aliment Pharmacol Ther 1996: 10: 777-86.
8. Silvennoinen JA, Karttunen TJ, Niemela SE. Manelius JJ, Lehtola JK. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut 1995: 37: 71-6.
9. Jahnsen J, Falch JA, Aadland E, Mowinckel P, Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: A population based study. Gut 1997: 40: 313-9.
10. Bjarnason I, Macpherson A, Mackintosh C. Buxton-Thomas M. Forgacs I, Moniz C. Reduced bone density in patients with inflammatory bowel disease. Gut 1997: 40: 228-33.
11. Boot AM, Bouquet J, Krenning EP. de Muinck Keizer-Schrama SMPF. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut 1998: 42: 188-94.
12. Gokhale R, Favus MJ, Karrison T, Sutton MM, Rich B, Kirschner BS. Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology 1998; 114: 902-11
13. Ghosh S, Cowen S, Hannan WJ, Ferguson A. Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 1994: 107: 1031-9.
14. Pollak RD, Karmeli F, Eliakim R, Ackerman Z. Rachmilewitz D. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease. Am J Gastroenterol 2000: 95: 699-704.
15. Vestergaard P, Krogh K, Rejnmark L, Laurberg S, Mosekilde L. Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut 2000: 46: 176-81.
16. Bernstein CN, Blanchard JF, Leslie W, Wajde A, Yu BN. The incidence of fracture among patients with inflammatory bowel disease - A population-based cohort study. Ann Intern Med 2000: 133: 795-9.
17. Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol 1998: 93: 1483-90.
18. Motley RJ, Crawley EO, Evans C, Rhodes J, Compston JE. Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease. Gut 1988: 29: 1332-6.
19. Motley RJ, Clements D. Evans WD, et al. A four-year longitudinal study of bone loss in patients with inflammatory bowel disease. Bone Miner 1993: 23: 95-104.
20. Schoon EJ, Blok BM. Geerling BJ, Russel MG, Stockbrugger RW, Brummer RJM. Bone mineral density in patients with recently diagnosed inflammatory bowel disease. Gastroenterology 2000: 119: 1203-8.
21. Andreassen H, Rungby J, Dahlerup JF, Mosekilde L, Inflammatory bowel disease and osteoporosis, Scand J Gastroenterol 1997: 32: 1247-55.
22. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomised trial. Br Med J 1989: 298: 82-6.
23. Harvey RF, Bradshaw JM, A simple index of Crohn's disease activity. Lancet 1980: 1: 514.
24. Drossman DA, Richter JE. Talley NJ. eds. The Functional Gastrointestinal Disorders: Diagnosis, Pathophysiology and Treatment. 1st edn. McLean, VA: Degnon Associates, 1994.
25. Looker AC, Wahner HW, Dunn WL. Proximal femur bone mineral levels of US adults. Osteoporosis Int 1995: 5: 389-409.
26. World Health Organization. Assessment of Fracture Risk and Its Application to Screening for Post-Menopausal Osteoporosis. Technical Report Series 843, Geneva: WHO, 1994.
27. Qasirm A, Seery J, Morain CAO. Osteoporosis in newly diagnosed inflammatory bowel disease. Gastroenterology 2001: 121: 504-5.
28. Driscoll RH, Meredith SC, Sitrin M, Rosenberg IH. Vitamin D deficiency and bone disease in patients with Crohn's disease. Gastroenterology 1982: 83; 1252-8.
29. Harries AD, Brown R, Heatley RV, Williams LA, Woodhead S. Rhodes J. Vitamin D status in Crohn's disease: Association with nutrition and disease activity. Gut 1985: 26: 1197-203.
30. Robinson RJ, Iqbal SJ, Abrams K, Al-Azzawi F, Mayberry JF, Increased bone resorption in patients with Crohn's disease. Aliment Pharmacol Ther 1998: 12: 699-705.
31. Dawson-Hughes B, Harris SS, Dallal GE, Plasma calcidiol. season, and serum parathyroid hormone concentrations in healthy elderly men and women. Am J Clin Nutr 1997: 65: 67-71.
32. Compston JE, Creamer B, Plasma levels and intestinal absorption of 25-hydroxyvitamin D in patients with small bowel resection. Gut 1977: 18: 171-5.
33. Chapuy M-C, Preziosi P, Maamer M. et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporosis Int 1997: 7: 439-43.
34. Heaney RP. Vitamin D: How much do we need, and how much is too much? Osteoporosis Int 2000: 11: 553-5.
35. Scharla SH, Minne HW, Lempert UG. et al. Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis). Exp Clin Endocrinol 1994: 102: 44-9.
36. Compston JE. Review article: Osteoporosis, corticosteroids and inflammatory bowel disease. Aliment Pharmacol Ther 1995: 9: 237-50.
37. Croucher PI, Vedi S, Motley RJ, Garrahan NJ, Stanton MR, Compston JE. Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease. Osteoporosis Int 1993: 3: 236-41.
38. Lin C, Moniz C, Chambers TJ, Chow JWM. Colitis causes bone loss in rats through suppression of bone formation. Gastroenterology 1996: 111: 1263-71.
39. Scott EM, Gaywood I, Scott BB. Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease, Gut 2000: 46(Suppl. 1): 1-8.
40. Vogelsang H, Ferenci P, Resch H, Kiss A, Gangl A. Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation. Eur J Gastroenterol Hepatol 1995: 7: 609-14.
41. Abitbol V, Mary JY, Roux C, et al. Osteoporosis in inflammatory bowel disease: Effect of calcium and vitamin D with or without fluoride. Aliment Pharmacol Ther 2002: 16: 919-27.
42. Nemetz A, Toth M, Garcia-Gonzalez MA, et al. Allelic variation at the interleukin 1B gene is associated with decreased bone mass in patients with inflammatory bowel diseases, Gut 2001: 49: 644-9.